	Analysis of Seroma Formation, Flap Necrosis, and Postoperative Pain Following Modified Radical Mastectomy in Patients With Breast Cancer: A Prospective Study. Cureus Ashok A, Chaudhary AK, Shanker P, Singh CS, Arti, Rana Y. PMID: 41262816 [PubMed]
	The promoter T-413A variant and elevated enzyme levels of heme oxygenase-1 associated with an increased risk of polycystic ovarian syndrome. Front Endocrinol (Lausanne) Wang Q, Liang J, Liu Q, Liu H, Bai H, Huang W, Fan P. PMID: 41262262 [PubMed - indexed for MEDLINE]
	Cancer genetics and response to oncolytic virus treatment for ovarian cancer. Pharmacogenomics Fletcher EL, Cudmore AO, Vanderhyden BC. PMID: 41261913 [PubMed - as supplied by publisher]
	Predicting neoadjuvant chemotherapy treatment response in hormone- receptor-positive/HER2-negative breast cancer - results from the Swedish SCAN-B population-based cohort. Acta Oncol Loman N, Saghir H, Kimbung S. PMID: 41261821 [PubMed - indexed for MEDLINE]
	The effects of upper versus lower extremity resistance training in patients with breast cancer: a systematic review. Acta Oncol Oncu H, Topcuoglu C, Cal, Saglam M, Vardar Yagl. PMID: 41261820 [PubMed - indexed for MEDLINE]
	Follistatin levels and endocrine disorders: A two-sample Mendelian randomization study. Medicine (Baltimore) Zhang W, Wu T, Zhao X, Ma Y, Han X. PMID: 41261668 [PubMed - indexed for MEDLINE]
	Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment. Integr Cancer Ther Greenlee H, Crew KD, Maurer M, Kalinsky K, Cremers S, Naini A, Tsai WY, Shi Z, Brogan F, Hershman DL. PMID: 41261512 [PubMed - indexed for MEDLINE]
	Management of Early and Metastatic Breast Cancer: A Consensus Statement from Oncologists in Saudi Arabia. Oncol Ther Alaklabi S, Al Refaei S, Abualkhair O, Abusanad A, Akhtar S, AlFoheidi M, Al-Hajeili M, Al-Tweigeri T, Alhashem H, Almufti R, Alsayed A, Alshehri A, Altwairgi A, Alzahrani M, Basulaiman B, Chelis L, Elsammani S, Madkhali I, Murshid E, Refae A, Suleman K, Abdelhafiz N, Kullab S. PMID: 41261349 [PubMed - as supplied by publisher]
	Impact of High-Risk HPV Infection on PI3K, MALAT1, H19 and LINC00460 Expression in Cervical Cells. J Cell Mol Med Neisi N, Mousavikish F, Bastani MN, Parsanahad M, Pirmoradi R. PMID: 41261348 [PubMed - indexed for MEDLINE]
	Translating genomic insights into therapy: an NGS-based mutation profiling study in breast cancer. Med Oncol Bhavnagari HM, Raval AP, Tarapara BV, Joshi JS, Shah FD. PMID: 41261306 [PubMed - indexed for MEDLINE]
	Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and risk of lifestyle-related cancers in the prostate, lung, colorectal, and ovarian cancer screening trial. BJC Rep Malcomson FC, Shams-White MM, Reedy J, Huang WY, Moore SC, Loftfield E. PMID: 41261199 [PubMed]
	Pre-operative Radiotherapy in Locally Advanced Breast Cancer: A Narrative Review. Int J Radiat Oncol Biol Phys Arif A, Khan AJ. PMID: 41260528 [PubMed - as supplied by publisher]
	Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02. Ann Oncol Hurvitz SA, Loi S, O'Shaughnessy J, Okines AFC, Tolaney SM, Sohn J, Saura C, Zhu X, Cameron D, Bachelot T, Hamilton E, Curigliano G, Wolff AC, Harbeck N, Masuda N, Vahdat L, Zaman K, Valdes-Albini F, Block M, Pluard T, Tan TJ, Gawryletz C, Chan A, Bedard PL, Yerushalmi R, Xu B, Schmitt M, Xie D, Borges VF, HER2CLIMB-02 study investigators. PMID: 41260264 [PubMed - as supplied by publisher]
	Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer. Ann Oncol Cabel L, Berger F, Bachelot T, Pistilli B, Dalenc F, Rouge TM, Sabatier R, Lortholary A, Marques S, Vibert J, Renault S, Hardy-Bessard AC, Delaloge S, Pradines A, Callens C, Bidard FC. PMID: 41260263 [PubMed - as supplied by publisher]
	ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY. Ann Oncol Toss A, Blondeaux E, Tenedini E, Bonamici L, Graffeo R, Livraghi L, Villarreal-Garza C, Molho RB, Kwong A, Balmana J, Wildiers H, Agostinetto E, Phillips KA, Pogoda K, Renaud T, Rousset-Jablonski C, Ferrari A, Moore HCF, Peccatori FA, Paluch-Shimon S, Fruscio R, Micheri C, Wong SM, Cui W, Vernieri C, Lee M, De Marchis L, Couch FJ, Del Mastro L, Puglisi F, Meireles PA, Kemp Z, Matikas A, Plichta J, Del Pilar Estevez-Diz M, Di Meglio A, Cichowska-Cwalinska N, Gianni C, Yerushalmi R, Sanchez-Bayona R, Mrinakova B, Matos L, Bianchini G, Caleffi M, Krivokuca A, Abdou Y, Mariño-Mariño M, Parokonnaya A, Okano M, Antone N, Saavedra C, Sonnenblick A, Duchnowska R, Pais HL, Harbeck N, Cortesi L, Delucchi V, De Angelis C, Lambertini M. PMID: 41260260 [PubMed - as supplied by publisher]
	Feet Cooling As a Preventive Strategy against Chemotherapy-Induced Peripheral Neuropathy in Advanced Breast Cancer Patients: A Randomized Clinical Trial. Clin Breast Cancer Asadi F, Emadi E, Chaman R, Porouhan P, Nematshahi M, PeyroShabany B, Zare MS, Javadinia SA. PMID: 41260178 [PubMed - as supplied by publisher]
	Diagnostic Heterogeneity and Healthcare Access Disparities: Latent Systemic Bias in Global Estimates of Male Breast Cancer Burden. Clin Breast Cancer Zhang J. PMID: 41260176 [PubMed - as supplied by publisher]
	CNT as a robust delivery vehicle for anti-breast cancer drugs: A combined DFT and in-silico study. J Mol Graph Model Pal S, Ghosh NN, Pati SK, Mandal M. PMID: 41260129 [PubMed - as supplied by publisher]
	Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysis. Eur J Cancer Secchi M, Signorelli M, Rulli E, Maruccio M, Di Martino G, Spadaro D, Giudice E, Turinetto M, Landoni F, Restaino S, Vizzielli G, Martinelli F, Lorusso D. PMID: 41259943 [PubMed - as supplied by publisher]
	Letter Re: Impact of early discontinuation of adjuvant endocrine therapy on survival in breast cancer: A target trial emulation. Eur J Cancer Woolpert KM, Collin LJ, Cronin-Fenton DP. PMID: 41259942 [PubMed - as supplied by publisher]

Articles 1 - 20 / 247519

Page 1 of 12376



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy